A clinical prediction model for myeloma has been shown to be “a robust and valuable tool” in a real-world population of Danish patients. The Myeloma Risk Profile (MRP) was developed by the UK Myeloma Research Alliance in 2019 to help aid decision making in patients who are ineligible for stem-cell transplantation. Based on data from ...
MRP a valuable risk assessment tool for newly diagnosed multiple myeloma
By Emma Wilkinson
16 Jun 2020